Theravance Biopharma logo
Theravance Biopharma
TBPH | NASDAQ
Chart Builder DCF Calculator
$17.03
$0.00 (0.00%)
At close: Sep 23, 2026, 4:00 PM ET

Theravance Biopharma Cash Flow Statement

Cash flow statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
105.9M -56.42M -55.19M -92.82M -265.07M -294.82M
5.64M 3.62M 4.26M 7.02M 8.6M 6.97M
18.48M 21.39M 25.37M 39.73M 62.06M 62.98M
147.24M 20.57M -7.66M 46.68M -37.82M -47.56M
-423K 7.09M 3.7M -183.28M 26.1M 12.25M
-11.52M -7.57M 3.21M – – –
120.47M 20.36M -8.34M 42.35M -39.55M -37.78M
238.54M -11.54M -27M -186.99M -207.86M -250.4M
-42K -332K -2.49M -572K -3.41M -6.62M
– – – – – –
-248.22M -143.04M -134.53M -103.15M -158.31M -401.99M
142.98M 155.65M 102.81M 158.02M 286.2M 419.26M
– – 1.51M 1.1B 6K 64K
-105.28M 12.28M -32.7M 1.15B 124.49M 10.72M
– – – -631.6M -10.73M 144.65M
-4.03M -3.1M -199.55M -132.28M -9.06M -9.75M
– – – – – –
– 508K 618K 5.08M 3.47M -11.73M
-3.25M -2.5M -198.93M -758.81M 91.86M 263.09M
130.01M -1.75M -258.63M 208.21M 8.5M 23.4M
238.5M -11.87M -29.49M -187.56M -211.26M -257.02M
220.02M -33.26M -54.86M -227.3M -273.33M -320M
– – – -572K -3.41M -6.62M
-42K -332K -2.49M – – –
238.54M -11.54M -27M -187.56M -211.26M -257.02M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.